시장보고서
상품코드
1181672

세계의 의약품 물류 시장 : 전망과 예측(2022-2027년)

Pharmaceutical Logistics Market - Global Outlook & Forecast 2022-2027

발행일: | 리서치사: Arizton Advisory & Intelligence | 페이지 정보: 영문 367 Pages | 배송안내 : 즉시배송

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 의약품 물류 시장 규모는 2022-2027년에 CAGR로 7.96%의 성장이 예측됩니다.

세계의 의약품 물류 시장에 대해 조사분석했으며, 시장 규모와 예측, 촉진요인, 경쟁 구도 등을 정리하여 전해드립니다.

목차

제1장 조사 방법

제2장 조사 목적

제3장 조사 프로세스

제4장 범위

제5장 리포트 전제조건과 주의사항

제6장 시장의 개요

제7장 서론

  • 배경
  • 세계의 공급망에 대한 COVID-19의 영향

제8장 주요 인사이트

제9장 시장 기회와 동향

제10장 시장 성장 촉진요인

제11장 시장 억제요인

제12장 시장 구도

  • 시장의 개요
  • 시장 규모와 예측
    • 인사이트 : 치료 분야별
    • 인사이트 : 유래별
    • 인사이트 : 제품별
    • 인사이트 : 기능별
    • 지역 : 지역별
  • Five forces 분석

제13장 치료 분야

  • 시장 스냅숏과 성장 엔진
  • 시장의 개요
  • 전염병
  • 종양
  • 당뇨병
  • 심혈관질환
  • 자가면역질환
  • 신경장애
  • 통증 관리
  • 호흡기질환
  • 기타

제14장 유래

  • 시장 스냅숏과 성장 엔진
  • 시장의 개요
  • 브랜드 의약품
  • 제네릭 의약품
  • OTC

제15장 제품

  • 시장 스냅숏과 성장 엔진
  • 시장의 개요
  • 저분자 의약품
  • 생물제제
  • 모노클로널 항체
  • 백신
  • 기타

제16장 기능

  • 시장 스냅숏과 성장 엔진
  • 시장의 개요
  • 운송
  • 육상
  • 수상
  • 항공
  • 보관
  • 기타

제17장 지역

  • 시장 스냅숏과 성장 엔진
  • 지역적 개요

제18장 북미

  • 시장의 개요
  • 시장 규모와 예측
  • 북미 : 치료 분야별
  • 북미 : 유래별
  • 북미 : 제품별
  • 북미 : 기능별
  • 주요 국가
    • 미국 : 시장 규모와 예측
    • 캐나다 : 시장 규모와 예측

제19장 유럽

  • 시장의 개요
  • 시장 규모와 예측
  • 유럽 : 치료 분야별
  • 유럽 : 유래별
  • 유럽 : 제품별
  • 유럽 : 기능별
  • 주요 국가
    • 독일 : 시장 규모와 예측
    • 프랑스 : 시장 규모와 예측
    • 영국 : 시장 규모와 예측
    • 이탈리아 : 시장 규모와 예측
    • 스페인 : 시장 규모와 예측

제20장 아시아태평양

  • 시장의 개요
  • 시장 규모와 예측
  • 아시아태평양 : 치료 분야별
  • 아시아태평양 : 유래별
  • 아시아태평양 : 제품별
  • 아시아태평양 : 기능별
  • 주요 국가
    • 중국 : 시장 규모와 예측
    • 일본 : 시장 규모와 예측
    • 인도 : 시장 규모와 예측
    • 한국 : 시장 규모와 예측
    • 호주 : 시장 규모와 예측

제21장 라틴아메리카

  • 시장의 개요
  • 시장 규모와 예측
  • 라틴아메리카 : 치료 분야별
  • 라틴아메리카 : 유래별
  • 라틴아메리카 : 제품별
  • 라틴아메리카 : 기능별
  • 주요 국가
    • 브라질 : 시장 규모와 예측
    • 멕시코 : 시장 규모와 예측
    • 아르헨티나 : 시장 규모와 예측

제22장 중동·아프리카

  • 시장의 개요
  • 시장 규모와 예측
  • 중동·아프리카 : 치료 분야별
  • 중동·아프리카 : 유래별
  • 중동·아프리카 : 제품별
  • 중동·아프리카 : 기능별
  • 주요 국가
    • 터키 : 시장 규모와 예측
    • 사우디아라비아 : 시장 규모와 예측
    • 남아프리카공화국 : 시장 규모와 예측

제23장 경쟁 구도

  • 경쟁의 개요
    • AMERISOURCEBERGEN
    • DB GROUP
    • DEUTSCHE POST DHL
    • CEVA LOGISTICS
    • UNITED PARCEL SERVICE
    • FEDEX
    • KUEHNE+NAGEL

제24장 주요 기업 개요

  • AMERISOURCEBERGEN
  • CEVA LOGISTICS
  • DB GROUP
  • DEUTSCHE POST DHL
  • FEDEX
  • KUEHNE+NAGEL
  • UNITED PARCEL SERVICE

제25장 기타 유명 벤더

  • ABS LOGISTICS
  • AWL INDIA
  • ALLOGA
  • BOLLORE LOGISTICS
  • CARDINAL HEALTH
  • C.H. ROBINSON
  • COLD CHAIN TECHNOLOGIES
  • CRYOPDP
  • DPD
  • DSV
  • FARMASOFT
  • JEENA & COMPANY
  • LUFTHANSA CARGO
  • A.P. MOLLER - MAERSK
  • MEDLINE
  • NIPPON EXPRESS
  • NOATUM LOGISTICS
  • OWENS & MINOR
  • OXIMIO
  • PHARMA LOGISTICS
  • PHOENIX GROUP
  • PAREXEL INTERNATIONAL
  • SEKO LOGISTICS
  • SINGAPORE POST
  • SINOTRANS
  • XPO LOGISTICS
  • YOURWAY
  • YUSEN LOGISTICS

제26장 리포트 요약

  • 주요 사항
  • 전략적 권장사항

제27장 정량적 요약

제28장 부록

KSA 23.01.19

The global pharmaceutical logistics market is expected to grow at a CAGR of 7.96% during 2022-2027.

MARKET OVERVIEW

Technological advancements are disrupting the logistics providers to improve the healthcare business model ecosystem, including pharmaceuticals. Further, increased usage of logistics optimization tools, AI, IoT, and intelligent logistics platforms are likely to contribute to the future growth of the pharmaceutical logistics market.

Pharmaceutical logistics deals with manufacturing, processing, shipping materials, and resources and activities related to handling manufactured goods by their customers. Logistics companies play a crucial role in the functioning of any pharmaceutical company. The growing adoption of water-based pharmaceutical logistics is one of the significant driving factors in the pharmaceutical logistics market. Pharmaceutical logistics showed a healthy growth rate even before the COVID-19 pandemic. The sector is undergoing several changes as the geriatric population drives the need for new pharma solutions. However, the COVID-19 pandemic has created complexities in the global supply chain that has impacted all the modes of freight transportation, from air to rail cargo, that may take months or years to get back to normal.

TRENDING FACTORS

Clinical research has recently become more globalized, with many of these studies being conducted globally and a significant increase in clinical trials in developing countries. The focus of clinical trial researchers is now shifting from developed markets of Japan, Australia, South Korea, and Singapore towards emerging economies like Thailand, China, the Philippines, and Vietnam.

Major companies are striving to offer cloud-based supply chain services and secured supply chain functions as it helps pharmaceutical manufacturers safeguard the validity of the drugs. These solutions are expected to prevent the production and distribution of counterfeit drugs. According to DB Schenker, a subsidiary of DB Group, to increase transport density and reliability, the shift to digital rail operations and digitalization of infrastructure and vehicles is essential in the pharmaceutical logistics market. Also, in 2019, TrakCel, one of the global leaders in managing clinical supply chain logistics, partnered with Quick Group to provide industry-leading digital supply chain IT solutions for cell and gene therapies. Also, the recent emergence of cell and gene therapy is expected to create lucrative opportunities for the pharmaceutical logistics market.

Driving Factors Of The Global Pharmaceutical Logistics Market:

  • Need for secure cold-chain solutions and increased monitoring
  • Evolving storage and transportation needs
  • Rising branded, generic, and OTC drugs

SEGMENTATION INSIGHTS

INSIGHTS BY THERAPY AREA

    • In therapy area segmentation, the communicable diseases segment dominated the global pharmaceutical logistics market with a share of 19.96% owing to the emergence of the COVID-19 pandemic that upsurged the communicable disease cases. According to the latest European Centre for Disease Prevention and Control (ECDC) report, tuberculosis remains one of the world's deadliest infectious diseases, second only to COVID-19, and drug-resistant TB strains are still a major concern that is made the communicable diseases dominant in the last few years. In 2019, communicable diseases ranked third with the highest number of cases, while the emergence of the COVID-19 pandemic dominated the segment in 2021. The upsurge in COVID-19 cases contributed to the highest share of communicable diseases, leading to increased demand for OTC medicines and vaccines.
    • The oncology segment accounted for the second-largest segment in the pharmaceutical logistics market with a revenue share of 15.17%, owing to growing cancer prevalence and demand for anti-tumor agents. It is also expected to grow at the highest CAGR of 14.02%. The current pharmaceuticals pipeline is disproportionately focused on cancer.
    • The world is expecting more pandemics in the future, particularly with monkeypox spreading in more than 60 countries which are expected to drive the demand for new medications and more clinical trials, thus boosting the demand for logistics during clinical trials and distributing products.

Segmentation by Therapy Area

  • Communicable Diseases
  • Oncology
  • Diabetes
  • Cardiovascular Diseases
  • Autoimmune Diseases
  • Neurological Disorders
  • Pain Management
  • Respiratory Diseases
  • Others

INSIGHTS BY ORIGIN

    • Under origin segmentation, branded drugs accounted for the highest revenue share in the global pharmaceutical logistics market. This is mainly due to their high preference and the high cost of branded drugs, which makes up the high revenue share of pharmaceutical logistics for branded drugs. According to the Association for Accessible Medicines, US Generic & Biosimilar Medicines Savings Report and National Sales Perspectives, in December 2020, branded drugs spending was around 80% of the share from 2018-2020. However, the generic drugs segment is expected to grow at the highest CAGR of 72.25% during the forecast period.

Segmentation by Origin

  • Branded
  • Generic
  • OTC

INSIGHTS BY PRODUCT

    • Under product segmentation, small molecule drugs dominate the global pharmaceutical logistics market with a revenue share of 63.02% in 2021 due to increasing demand and its cost-effectiveness, ease of administration, and easy dosing. The demand for small-molecule drugs remains high, with figures showing that 97% of marketed drugs are classified as small molecules. However, biologics lead among the top-selling products and new sales generators projected for 2022, whereas small molecules continue to lead in new drug approvals. According to US FDA's Center for Drug Evaluation and Research, of the 50 new molecular entities approved by the US FDA's Center for Drug Evaluation and Research in 2021, 36 (72%) were small molecules, and 14(28%) were biologics.

Segmentation by Product

  • Small Molecule Drugs
  • Biologics

INSIGHTS BY FUNCTION

    • As transportation is a crucial part of the logistics chain, thus it accounts for the highest revenue share of 71.66% in the pharmaceutical logistics market in 2021 and continues to grow with the highest CAGR of 8.20% during the forecast period. The demand for temperature-controlled transportation is also rising to maintain the quality of the products. Road transportation dominates the transportation segment with a revenue share of 66.38% in 2021, whereas the water and air transportation segments accounted for 21.21% and 12.41%, respectively, in the same year. The highest share of road transportation can be attributed to its low cost in terms of workforce and operation. In January 2021, more than 58% of US-Canada cross-border freight was moved by trucks, followed by rail with more than 16% of cross-border freight.
    • However, in 2020, European land transport declined because of the COVID-19 pandemic. Between April and August 2020, after decreased prices and falling demand, prices grew exponentially to the previous year's level from October 2020, and the demand increased significantly. As the air rates are higher than water and road, thus the demand for logistics via air is lowest.
    • Air freight is 78% more expensive than ocean freight, leading the pack with 80% of all temperature excursions for pharmaceutical products transportation. In comparison, ocean transportation has a mere 1% temperature excursion rate, while road transport is a little higher, with 18% of all the excursions. There is still a lot of work for the air cargo supply chain to come up to speed for the growing global trade in pharmaceutical products. Despite that, the global pharmaceutical logistics market by air is growing at the fastest CAGR of 9.16% during the forecast period.

Segmentation by Function

  • Transportation
  • Warehousing
  • Others

GEOGRAPHY INSIGHTS

  • North America region accounts for the highest revenue share of 38.70% in the global pharmaceutical logistics market in 2021 and holds the presence of most pharmaceutical suppliers. The US is the leading country worldwide with the highest share of pharmaceuticals. About five of the ten top pharmaceutical companies in 2020 were from the US. In the US, branded drugs accounted for around 83.9% of spending. In 2020, about 8.1% of worldwide drug and medicine shipments originated from North America.
  • North America and Europe have accounted for about 80% of monoclonal antibodies market share alone; thus, the growing demand for biologics, i.e., vaccines and monoclonal antibodies, and increasing investments in R&D are the major driving factors for the pharmaceutical logistics market. Europe is the number one exporter of pharmaceutical drugs. The pharmaceutical logistics demand in Europe is driven by the growing demand for biologics such as vaccines, propelled by the COVID-19 pandemic and growing investments by leading pharmaceutical firms. In 2019, pharmaceutical industry sales in the country increased by 5.7%, reaching about USD 52.1 billion. More than 500 pharmaceutical companies are in Germany. Small and mid-size enterprises (SMEs) constitute the backbone of the economic sector, with around 90% of drug manufacturers. In 2018, Germany generated a production value of USD 42.1 billion, making it the leading pharmaceutical manufacturing country in Europe.
  • The pharmaceutical logistics market in APAC was valued at USD 20.79 billion in 2021. Asia Pacific is the largest manufacturing region and provider of generic drugs, vaccines, OTC drugs, biosimilars, custom research manufacturing, and active pharmaceutical ingredients; many countries are importing pharmaceuticals from this region. Hence, the growing demand for these pharmaceutical products is the major driving factor for transportation and warehousing activities in the region. India has the highest share of about 20% of the global supply volume. Moreover, it contributes to around 60% of global vaccines. India majorly exports biologics, which contribute to about 75% of the total pharmaceutical exports out of India. In addition, Latin America, the Middle East & Africa, and the APAC region are the major emerging markets for pharmaceutical logistics market growth. Factors such as rapid population growth, steady increase in the elderly population, and increased prevalence of chronic, non-communicable diseases are the major driving factors in these regions for growth in the pharmaceutical logistics market.

Segmentation by Geography

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • Italy
    • Spain
    • France
    • UK
  • APAC
    • Japan
    • China
    • South Korea
    • India
    • Australia
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • South Africa

VENDOR LANDSCAPE

AmerisourceBergen, CEVA Logistics, Deutsch Post DHL, FedEx, Kuehne + Nagel, DB Schenker, and UPS are the key vendors in the pharmaceutical logistics market. These companies have a broad geographical footprint, a strong focus on innovation in logistics, and a diversified service portfolio. Upcoming new advanced technologies and increased demand for personalized medicines are providing lucrative opportunities for stakeholders to take the companies to the next level. Technologies such as data mining, mobile cloud, time analytics, and blockchain are expected to create better app interfaces and cloud infrastructure, which is expected to provide better growth opportunities in the post-pandemic pharmaceutical logistics market.

In addition to technological advances, companies invest in inorganic growth methods such as acquisitions. For instance, on June 2, 2021, the leading company, AmerisourceBergen, completed the acquisition of most of Walgreens Boots Alliance's Alliance Healthcare businesses for USD 6.27 billion cash which will help the company expand its reach and solutions in pharmaceutical distribution. Similarly, In August 2021, the leading company Deutsche Post DHL Group, signed an agreement to acquire 100% of J.F. Hillebrand Group and its subsidiaries.

Key Vendors

  • AmerisourceBergen
  • CEVA Logistics
  • DB Group
  • Deutsche Post DHL
  • FedEx
  • Kuehne + Nagel
  • United Parcel Service

Other Prominent Vendors

  • ABS Logistics
  • AWL India
  • Alloga
  • BOLLORE LOGISTICS
  • Cardinal Health
  • C.H. Robinson
  • Cold Chain Technologies
  • CRYOPDP
  • DPD
  • DSV
  • Farmasoft
  • Jeena & Company
  • Lufthansa Cargo
  • Maersk
  • Medline
  • Nippon Express
  • Noatum Logistics
  • Owens & Minor
  • Oximio
  • Pharma Logistics
  • PHOENIX Group
  • Parexel International
  • SEKO Logistics
  • Singapore Post
  • SINOTRANS
  • XPO Logistics
  • Yourway
  • YUSEN LOGISTICS

KEY QUESTIONS ANSWERED

  • 1. How big is the pharmaceutical logistics market?
  • 2. What is the pharmaceutical logistics market growth?
  • 3. What are the trends in the global pharmaceutical logistics market?
  • 4. Which region holds the largest pharmaceutical logistics market share globally?
  • 5. Which are the leading companies in the global pharmaceutical logistics market?
  • 6. What is the leading product in the pharmaceutical logistics market?

TABLE OF CONTENTS

1 RESEARCH METHODOLOGY

2 RESEARCH OBJECTIVES

3 RESEARCH PROCESS

4 SCOPE & COVERAGE

  • 4.1 MARKET DEFINITION
    • 4.1.1 INCLUSIONS
    • 4.1.2 EXCLUSIONS
    • 4.1.3 MARKET ESTIMATION CAVEATS
  • 4.2 BASE YEAR
  • 4.3 SCOPE OF THE STUDY
    • 4.3.1 MARKET SEGMENTATION BY THERAPY AREA
    • 4.3.2 MARKET SEGMENTATION BY ORIGIN
    • 4.3.3 MARKET SEGMENTATION BY PRODUCT
    • 4.3.4 MARKET SEGMENTATION BY FUNCTION
    • 4.3.5 MARKET SEGMENTATION BY GEOGRAPHY

5 REPORT ASSUMPTIONS & CAVEATS

  • 5.1 KEY CAVEATS
  • 5.2 CURRENCY CONVERSION
  • 5.3 MARKET DERIVATION

6 MARKET AT A GLANCE

7 INTRODUCTION

  • 7.1 BACKGROUND
  • 7.2 IMPACT OF COVID-19 ON GLOBAL SUPPLY CHAIN

8 PREMIUM INSIGHTS

9 MARKET OPPORTUNITIES & TRENDS

  • 9.1 GROWING DEMAND FOR CLINICAL TRIALS LOGISTICS
  • 9.2 DIGITAL TRANSFORMATIONS IN PHARMA LOGISTICS
  • 9.3 INCREASING DEMAND FOR CELL & GENE THERAPY LOGISTICS

10 MARKET GROWTH ENABLERS

  • 10.1 INCREASING DEMAND FOR TEMPERATURE-SENSITIVE MEDICINES
  • 10.2 GROWING DEMAND FOR OCEAN FREIGHT SERVICE
  • 10.3 INCREASING DEMAND FOR GENERICS AND BIOSIMILARS

11 MARKET RESTRAINTS

  • 11.1 LACK OF COMPLIANCE AND CHANGING REGULATIONS
  • 11.2 IMPACT OF COVID-19 PANDEMIC
  • 11.3 GEOPOLITICAL RISKS & CHANGES IN INTERNATIONAL TRADE POLICIES AND RELATIONS

12 MARKET LANDSCAPE

  • 12.1 MARKET OVERVIEW
  • 12.2 MARKET SIZE & FORECAST
    • 12.2.1 INSIGHTS BY THERAPY AREA
    • 12.2.2 INSIGHTS BY ORIGIN
    • 12.2.3 INSIGHTS BY PRODUCT
    • 12.2.4 INSIGHTS BY FUNCTION
    • 12.2.5 INSIGHTS BY GEOGRAPHY
  • 12.3 FIVE FORCES ANALYSIS
    • 12.3.1 THREAT OF NEW ENTRANTS
    • 12.3.2 BARGAINING POWER OF SUPPLIERS
    • 12.3.3 BARGAINING POWER OF BUYERS
    • 12.3.4 THREAT OF SUBSTITUTES
    • 12.3.5 COMPETITIVE RIVALRY

13 THERAPY AREA

  • 13.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 13.2 MARKET OVERVIEW
  • 13.3 COMMUNICABLE DISEASES
    • 13.3.1 MARKET OVERVIEW
    • 13.3.2 MARKET SIZE & FORECAST
    • 13.3.3 MARKET BY GEOGRAPHY
  • 13.4 ONCOLOGY
    • 13.4.1 MARKET OVERVIEW
    • 13.4.2 MARKET SIZE & FORECAST
    • 13.4.3 MARKET BY GEOGRAPHY
  • 13.5 DIABETES
    • 13.5.1 MARKET OVERVIEW
    • 13.5.2 MARKET SIZE & FORECAST
    • 13.5.3 MARKET BY GEOGRAPHY
  • 13.6 CARDIOVASCULAR DISEASES
    • 13.6.1 MARKET OVERVIEW
    • 13.6.2 MARKET SIZE & FORECAST
    • 13.6.3 MARKET BY GEOGRAPHY
  • 13.7 AUTOIMMUNE DISEASES
    • 13.7.1 MARKET OVERVIEW
    • 13.7.2 MARKET SIZE & FORECAST
    • 13.7.3 MARKET BY GEOGRAPHY
  • 13.8 NEUROLOGICAL DISORDERS
    • 13.8.1 MARKET OVERVIEW
    • 13.8.2 MARKET SIZE & FORECAST
    • 13.8.3 MARKET BY GEOGRAPHY
  • 13.9 PAIN MANAGEMENT
    • 13.9.1 MARKET OVERVIEW
    • 13.9.2 MARKET SIZE & FORECAST
    • 13.9.3 MARKET BY GEOGRAPHY
  • 13.10 RESPIRATORY DISEASES
    • 13.10.1 MARKET OVERVIEW
    • 13.10.2 MARKET SIZE & FORECAST
    • 13.10.3 MARKET BY GEOGRAPHY
  • 13.11 OTHERS
    • 13.11.1 MARKET OVERVIEW
    • 13.11.2 MARKET SIZE & FORECAST
    • 13.11.3 MARKET BY GEOGRAPHY

14 ORIGIN

  • 14.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 14.2 MARKET OVERVIEW
  • 14.3 BRANDED DRUGS
    • 14.3.1 MARKET OVERVIEW
    • 14.3.2 MARKET SIZE & FORECAST
    • 14.3.3 MARKET BY GEOGRAPHY
  • 14.4 GENERIC DRUGS
    • 14.4.1 MARKET OVERVIEW
    • 14.4.2 MARKET SIZE & FORECAST
    • 14.4.3 MARKET BY GEOGRAPHY
  • 14.5 OTC
    • 14.5.1 MARKET OVERVIEW
    • 14.5.2 MARKET SIZE & FORECAST
    • 14.5.3 MARKET BY GEOGRAPHY

15 PRODUCT

  • 15.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 15.2 MARKET OVERVIEW
  • 15.3 SMALL MOLECULE DRUGS
    • 15.3.1 MARKET OVERVIEW
    • 15.3.2 MARKET SIZE & FORECAST
    • 15.3.3 MARKET BY GEOGRAPHY
  • 15.4 BIOLOGICS
    • 15.4.1 MARKET OVERVIEW
    • 15.4.2 MARKET SIZE & FORECAST
    • 15.4.3 MARKET BY GEOGRAPHY
  • 15.5 MONOCLONAL ANTIBODIES
    • 15.5.1 MARKET OVERVIEW
    • 15.5.2 MARKET SIZE & FORECAST
  • 15.6 VACCINES
    • 15.6.1 MARKET OVERVIEW
    • 15.6.2 MARKET SIZE & FORECAST
  • 15.7 OTHERS
    • 15.7.1 MARKET OVERVIEW
    • 15.7.2 MARKET SIZE & FORECAST

16 FUNCTION

  • 16.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 16.2 MARKET OVERVIEW
  • 16.3 TRANSPORTATION
    • 16.3.1 MARKET OVERVIEW
    • 16.3.2 MARKET SIZE & FORECAST
    • 16.3.3 MARKET BY GEOGRAPHY
  • 16.4 ROAD
    • 16.4.1 MARKET OVERVIEW
    • 16.4.2 MARKET SIZE & FORECAST
  • 16.5 WATER
    • 16.5.1 MARKET OVERVIEW
    • 16.5.2 MARKET SIZE & FORECAST
  • 16.6 AIR
    • 16.6.1 MARKET OVERVIEW
    • 16.6.2 MARKET SIZE & FORECAST
  • 16.7 WAREHOUSING
    • 16.7.1 MARKET OVERVIEW
    • 16.7.2 MARKET SIZE & FORECAST
    • 16.7.3 MARKET BY GEOGRAPHY
  • 16.8 OTHERS
    • 16.8.1 MARKET OVERVIEW
    • 16.8.2 MARKET SIZE & FORECAST
    • 16.8.3 MARKET BY GEOGRAPHY

17 GEOGRAPHY

  • 17.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 17.2 GEOGRAPHIC OVERVIEW

18 NORTH AMERICA

  • 18.1 MARKET OVERVIEW
  • 18.2 MARKET SIZE & FORECAST
  • 18.3 NORTH AMERICA BY THERAPY AREA
  • 18.4 NORTH AMERICA BY ORIGIN
  • 18.5 NORTH AMERICA BY PRODUCT
  • 18.6 NORTH AMERICA BY FUNCTION
  • 18.7 KEY COUNTRIES
    • 18.7.1 US: MARKET SIZE & FORECAST
    • 18.7.2 CANADA: MARKET SIZE & FORECAST

19 EUROPE

  • 19.1 MARKET OVERVIEW
  • 19.2 MARKET SIZE & FORECAST
  • 19.3 EUROPE BY THERAPY AREA
  • 19.4 EUROPE BY ORIGIN
  • 19.5 EUROPE BY PRODUCT
  • 19.6 EUROPE BY FUNCTION
  • 19.7 KEY COUNTRIES
    • 19.7.1 GERMANY: MARKET SIZE & FORECAST
    • 19.7.2 FRANCE: MARKET SIZE & FORECAST
    • 19.7.3 UK: MARKET SIZE & FORECAST
    • 19.7.4 ITALY: MARKET SIZE & FORECAST
    • 19.7.5 SPAIN: MARKET SIZE & FORECAST

20 APAC

  • 20.1 MARKET OVERVIEW
  • 20.2 MARKET SIZE & FORECAST
  • 20.3 APAC BY THERAPY AREA
  • 20.4 APAC BY ORIGIN
  • 20.5 APAC BY PRODUCT
  • 20.6 APAC BY FUNCTION
  • 20.7 KEY COUNTRIES
    • 20.7.1 CHINA: MARKET SIZE & FORECAST
    • 20.7.2 JAPAN: MARKET SIZE & FORECAST
    • 20.7.3 INDIA: MARKET SIZE & FORECAST
    • 20.7.4 SOUTH KOREA: MARKET SIZE & FORECAST
    • 20.7.5 AUSTRALIA: MARKET SIZE & FORECAST

21 LATIN AMERICA

  • 21.1 MARKET OVERVIEW
  • 21.2 MARKET SIZE & FORECAST
  • 21.3 LATIN AMERICA BY THERAPY AREA
  • 21.4 LATIN AMERICA BY ORIGIN
  • 21.5 LATIN AMERICA BY PRODUCT
  • 21.6 LATIN AMERICA BY FUNCTION
  • 21.7 KEY COUNTRIES
    • 21.7.1 BRAZIL: MARKET SIZE & FORECAST
    • 21.7.2 MEXICO: MARKET SIZE & FORECAST
    • 21.7.3 ARGENTINA: MARKET SIZE & FORECAST

22 MIDDLE EAST & AFRICA

  • 22.1 MARKET OVERVIEW
  • 22.2 MARKET SIZE & FORECAST
  • 22.3 MIDDLE EAST & AFRICA BY THERAPY AREA
  • 22.4 MIDDLE EAST & AFRICA BY ORIGIN
  • 22.5 MIDDLE EAST & AFRICA BY PRODUCT
  • 22.6 MIDDLE EAST & AFRICA BY FUNCTION
  • 22.7 KEY COUNTRIES
    • 22.7.1 TURKEY: MARKET SIZE & FORECAST
    • 22.7.2 SAUDI ARABIA: MARKET SIZE & FORECAST
    • 22.7.3 SOUTH AFRICA: MARKET SIZE & FORECAST

23 COMPETITIVE LANDSCAPE

  • 23.1 COMPETITION OVERVIEW
    • 23.1.1 AMERISOURCEBERGEN
    • 23.1.2 DB GROUP
    • 23.1.3 DEUTSCHE POST DHL
    • 23.1.4 CEVA LOGISTICS
    • 23.1.5 UNITED PARCEL SERVICE
    • 23.1.6 FEDEX
    • 23.1.7 KUEHNE+NAGEL

24 KEY COMPANY PROFILES

  • 24.1 AMERISOURCEBERGEN
    • 24.1.1 BUSINESS OVERVIEW
    • 24.1.2 SERVICE OFFERINGS
    • 24.1.3 KEY STRATEGIES
    • 24.1.4 KEY STRENGTHS
    • 24.1.5 KEY OPPORTUNITIES
  • 24.2 CEVA LOGISTICS
    • 24.2.1 BUSINESS OVERVIEW
    • 24.2.2 SERVICE OFFERINGS
    • 24.2.3 KEY STRATEGIES
    • 24.2.4 KEY STRENGTHS
    • 24.2.5 KEY OPPORTUNITIES
  • 24.3 DB GROUP
    • 24.3.1 BUSINESS OVERVIEW
    • 24.3.2 SERVICE OFFERINGS
    • 24.3.3 KEY STRATEGIES
    • 24.3.4 KEY STRENGTHS
    • 24.3.5 KEY OPPORTUNITIES
  • 24.4 DEUTSCHE POST DHL
    • 24.4.1 BUSINESS OVERVIEW
    • 24.4.2 SERVICE OFFERINGS
    • 24.4.3 KEY STRATEGIES
    • 24.4.4 KEY STRENGTHS
    • 24.4.5 KEY OPPORTUNITIES
  • 24.5 FEDEX
    • 24.5.1 BUSINESS OVERVIEW
    • 24.5.2 SERVICE OFFERINGS
    • 24.5.3 KEY STRATEGIES
    • 24.5.4 KEY STRENGTHS
    • 24.5.5 KEY OPPORTUNITIES
  • 24.6 KUEHNE + NAGEL
    • 24.6.1 BUSINESS OVERVIEW
    • 24.6.2 SERVICE OFFERINGS
    • 24.6.3 KEY STRATEGIES
    • 24.6.4 KEY STRENGTHS
    • 24.6.5 KEY OPPORTUNITIES
  • 24.7 UNITED PARCEL SERVICE
    • 24.7.1 BUSINESS OVERVIEW
    • 24.7.2 SERVICE OFFERINGS
    • 24.7.3 KEY STRATEGIES
    • 24.7.4 KEY STRENGTHS
    • 24.7.5 KEY OPPORTUNITIES

25 OTHER PROMINENT VENDORS

  • 25.1 ABS LOGISTICS
    • 25.1.1 BUSINESS OVERVIEW
    • 25.1.2 SERVICE OFFERINGS
  • 25.2 AWL INDIA
    • 25.2.1 BUSINESS OVERVIEW
    • 25.2.2 SERVICE OFFERINGS
  • 25.3 ALLOGA
    • 25.3.1 BUSINESS OVERVIEW
    • 25.3.2 SERVICE OFFERINGS
  • 25.4 BOLLORE LOGISTICS
    • 25.4.1 BUSINESS OVERVIEW
    • 25.4.2 SERVICE OFFERINGS
  • 25.5 CARDINAL HEALTH
    • 25.5.1 BUSINESS OVERVIEW
    • 25.5.2 SERVICE OFFERINGS
  • 25.6 C.H. ROBINSON
    • 25.6.1 BUSINESS OVERVIEW
    • 25.6.2 SERVICE OFFERINGS
  • 25.7 COLD CHAIN TECHNOLOGIES
    • 25.7.1 BUSINESS OVERVIEW
    • 25.7.2 SERVICE OFFERINGS
  • 25.8 CRYOPDP
    • 25.8.1 BUSINESS OVERVIEW
    • 25.8.2 SERVICE OFFERINGS
  • 25.9 DPD
    • 25.9.1 BUSINESS OVERVIEW
    • 25.9.2 SERVICE OFFERINGS
  • 25.10 DSV
    • 25.10.1 BUSINESS OVERVIEW
    • 25.10.2 SERVICE OFFERINGS
  • 25.11 FARMASOFT
    • 25.11.1 BUSINESS OVERVIEW
    • 25.11.2 SERVICE OFFERINGS
  • 25.12 JEENA & COMPANY
    • 25.12.1 BUSINESS OVERVIEW
    • 25.12.2 SERVICE OFFERINGS
  • 25.13 LUFTHANSA CARGO
    • 25.13.1 BUSINESS OVERVIEW
    • 25.13.2 SERVICE OFFERINGS
  • 25.14 A.P. MOLLER - MAERSK
    • 25.14.1 BUSINESS OVERVIEW
    • 25.14.2 SERVICE OFFERINGS
  • 25.15 MEDLINE
    • 25.15.1 BUSINESS OVERVIEW
    • 25.15.2 SERVICE OFFERINGS
  • 25.16 NIPPON EXPRESS
    • 25.16.1 BUSINESS OVERVIEW
    • 25.16.2 SERVICE OFFERINGS
  • 25.17 NOATUM LOGISTICS
    • 25.17.1 BUSINESS OVERVIEW
    • 25.17.2 SERVICE OFFERINGS
  • 25.18 OWENS & MINOR
    • 25.18.1 BUSINESS OVERVIEW
    • 25.18.2 SERVICE OFFERINGS
  • 25.19 OXIMIO
    • 25.19.1 BUSINESS OVERVIEW
    • 25.19.2 SERVICE OFFERINGS
  • 25.20 PHARMA LOGISTICS
    • 25.20.1 BUSINESS OVERVIEW
    • 25.20.2 SERVICE OFFERINGS
  • 25.21 PHOENIX GROUP
    • 25.21.1 BUSINESS OVERVIEW
    • 25.21.2 SERVICE OFFERINGS
  • 25.22 PAREXEL INTERNATIONAL
    • 25.22.1 BUSINESS OVERVIEW
    • 25.22.2 SERVICE OFFERINGS
  • 25.23 SEKO LOGISTICS
    • 25.23.1 BUSINESS OVERVIEW
    • 25.23.2 SERVICE OFFERINGS
  • 25.24 SINGAPORE POST
    • 25.24.1 BUSINESS OVERVIEW
    • 25.24.2 SERVICE OFFERINGS
  • 25.25 SINOTRANS
    • 25.25.1 BUSINESS OVERVIEW
    • 25.25.2 SERVICE OFFERINGS
  • 25.26 XPO LOGISTICS
    • 25.26.1 BUSINESS OVERVIEW
    • 25.26.2 SERVICE OFFERINGS
  • 25.27 YOURWAY
    • 25.27.1 BUSINESS OVERVIEW
    • 25.27.2 SERVICE OFFERINGS
  • 25.28 YUSEN LOGISTICS
    • 25.28.1 BUSINESS OVERVIEW
    • 25.28.2 SERVICE OFFERINGS

26 REPORT SUMMARY

  • 26.1 KEY TAKEAWAYS
  • 26.2 STRATEGIC RECOMMENDATIONS

27 QUANTITATIVE SUMMARY

  • 27.1 MARKET BY GEOGRAPHY
  • 27.2 MARKET BY THERAPY AREA
  • 27.3 MARKET BY ORIGIN
  • 27.4 MARKET BY PRODUCT
  • 27.5 MARKET BY FUNCTION
  • 27.6 NORTH AMERICA BY THERAPY AREA
  • 27.7 NORTH AMERICA BY ORIGIN
  • 27.8 NORTH AMERICA BY PRODUCT
  • 27.9 NORTH AMERICA BY FUNCTION
  • 27.10 EUROPE BY THERAPY AREA
  • 27.11 EUROPE BY ORIGIN
  • 27.12 EUROPE BY PRODUCT
  • 27.13 EUROPE BY FUNCTION
  • 27.14 APAC BY THERAPY AREA
  • 27.15 APAC BY ORIGIN
  • 27.16 APAC BY PRODUCT
  • 27.17 APAC BY FUNCTION
  • 27.18 LATIN AMERICA BY THERAPY AREA
  • 27.19 LATIN AMERICA BY ORIGIN
  • 27.20 LATIN AMERICA BY PRODUCT
  • 27.21 LATIN AMERICA BY FUNCTION
  • 27.22 MIDDLE EAST & AFRICA AMERICA BY THERAPY AREA
  • 27.23 MIDDLE EAST & AFRICA BY ORIGIN
  • 27.24 MIDDLE EAST & AFRICA BY PRODUCT
  • 27.25 MIDDLE EAST & AFRICA BY FUNCTION

28 APPENDIX

  • 28.1 ABBREVIATIONS
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제